Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1790270
Max Phase: Preclinical
Molecular Formula: C54H72N10O9
Molecular Weight: 1005.23
Molecule Type: Small molecule
Associated Items:
ID: ALA1790270
Max Phase: Preclinical
Molecular Formula: C54H72N10O9
Molecular Weight: 1005.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C54H72N10O9/c1-6-34(4)48(63-51(70)43(28-38-21-14-9-15-22-38)62-52(71)45-23-16-24-64(45)54(73)44(58-35(5)65)29-39-31-56-32-57-39)53(72)60-40(26-36-17-10-7-11-18-36)46(66)30-47(67)59-42(25-33(2)3)50(69)61-41(49(55)68)27-37-19-12-8-13-20-37/h7-15,17-22,31-34,40-46,48,66H,6,16,23-30H2,1-5H3,(H2,55,68)(H,56,57)(H,58,65)(H,59,67)(H,60,72)(H,61,69)(H,62,71)(H,63,70)/t34-,40+,41+,42+,43+,44+,45-,46+,48+/m1/s1
Standard InChI Key: PUHFKIAHJYNLBU-NKKDIBGVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1005.23 | Molecular Weight (Monoisotopic): 1004.5484 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E.. (1988) Design of rat renin inhibitory peptides., 31 (9): [PMID:3045320] [10.1021/jm00117a003] |
Source(1):